XML 26 R17.htm IDEA: XBRL DOCUMENT v3.23.3
FAIR VALUE OF FINANCIAL INSTRUMENTS
9 Months Ended
Sep. 30, 2023
Fair Value Disclosures [Abstract]  
FAIR VALUE OF FINANCIAL INSTRUMENTS FAIR VALUE OF FINANCIAL INSTRUMENTS
 
Forward Foreign Exchange and Currency Option Contracts
 
The Corporation has foreign currency exposure primarily in the United Kingdom, Europe, and Canada. The Corporation uses financial instruments, such as forward and option contracts, to hedge a portion of existing and anticipated foreign currency denominated transactions. The purpose of the Corporation’s foreign currency risk management program is to reduce volatility in earnings caused by exchange rate fluctuations. Guidance on accounting for derivative instruments and hedging activities requires companies to recognize all of the derivative financial instruments as either assets or liabilities at fair value in the Condensed Consolidated Balance Sheets based upon quoted market prices for comparable instruments.
 
Interest Rate Risks and Related Strategies
 
The Corporation’s primary interest rate exposure results from changes in U.S. dollar interest rates. The Corporation’s policy is to manage interest cost using a mix of fixed and variable rate debt.

Effects on Condensed Consolidated Balance Sheets

As of September 30, 2023 and December 31, 2022, the fair values of the asset and liability derivative instruments were immaterial.

Effects on Condensed Consolidated Statements of Earnings
 
Undesignated hedges

The gains and losses on forward exchange derivative contracts not designated for hedge accounting are recognized to general and administrative expenses within the Condensed Consolidated Statements of Earnings. The gains and (losses) for the three and nine months ended September 30, 2023 were ($5) million and $2 million, respectively. The losses for the three and nine months ended September 30, 2022 were $6 million and $12 million, respectively.

Debt

The estimated fair value amounts were determined by the Corporation using available market information that is primarily based on quoted market prices for the same or similar issuances as of September 30, 2023. Accordingly, all of the Corporation’s debt is valued as a Level 2 financial instrument. The fair values described below may not be indicative of net realizable value or reflective of future fair values. Furthermore, the use of different methodologies to determine the fair value of certain financial instruments could result in a different estimate of fair value at the reporting date.
September 30, 2023December 31, 2022
(In thousands)Carrying ValueEstimated Fair ValueCarrying ValueEstimated Fair Value
3.70% Senior notes due 2023
— — 202,500 202,082 
3.85% Senior notes due 2025
90,000 87,108 90,000 87,298 
4.24% Senior notes due 2026
200,000 190,364 200,000 191,760 
4.05% Senior notes due 2028
67,500 62,555 67,500 63,300 
4.11% Senior notes due 2028
90,000 82,716 90,000 83,955 
3.10% Senior notes due 2030
150,000 124,941 150,000 127,429 
3.20% Senior notes due 2032
150,000 119,769 150,000 123,656 
4.49% Senior notes due 2032
200,000 176,107 200,000 183,007 
4.64% Senior notes due 2034
100,000 86,470 100,000 90,341 
Total debt1,047,500 930,030 1,250,000 1,152,828 
Debt issuance costs, net(1,597)(1,597)(1,631)(1,631)
Unamortized interest rate swap proceeds4,810 4,810 6,031 6,031 
Total debt, net$1,050,713 $933,243 $1,254,400 $1,157,228